According to Viracta Therapeutics's latest financial reports the company's current earnings (TTM) are -โน3.81 B. In 2023 the company made an earning of -โน4.29 B a decrease over its 2022 earnings that were of -โน4.13 B.The earnings displayed on this page is the company's Pretax Income.